Shionogi Announces FDA Approval of Kapvay - The First and Only Therapy Approved for Use with Stimulant Medication for the Treatment of ADHD
Links shared publicly online about this topic.
- 825total visits
Shionogi Announces FDA Approval of Kapvay - The First and Only Therapy Approved for Use with Stimulant Medication for the Treatment of ADHD
Kapvay (clonidine hydrochloride) is used to treat Attention Deficit Hyperactivity Disorder (ADHD). Includes Kapvay side effects, interactions and indications.
View full resource at drugs.com
Tags: High Blood Pressure Medication, ADHD, Disease and Condition, Drug, FDA, Catapres, Shionogi
Most Recently Shared on October 4, 2010 at 11:57 pm By:
FDA Approves Kapvay for the Treatment of ADHD - http://bit.ly/9mCUK6
Shionogi Announces FDA Approval Of KAPVAY™ - The First And Only Therapy Approved For Use With Stimulant Medication For The Treatment Of ADHD
medicalnewstoday.com — “Shionogi Inc., the U.S.-based group company of Shionogi & Co., Ltd., announced the U.S. Food and Drug Administration approval of the non-stimulant medication KAPVAY™ (clonidine hydrochloride” View full resource at medicalnewstoday.com
Most Recently Shared on October 6, 2010 at 3:05 pm By:
MNT ADHD & ADD News Health News
Shionogi Announces FDA Approval Of KAPVAY™ - The First And Only Therapy Approved For Use With Stimulant Medicati... http://mnt.to/3KPx
Advertisement
